Stockreport

Invivyd: A Logical Bull Thesis With A Major Catalyst Approaching [Seeking Alpha]

Invivyd, Inc.  (IVVD) 
PDF IVVD's Pemgarda generated $53.4M in 2025 revenue, but fell short of management expectations; net loss narrowed to $(52.5M) from $(170M) prior year. IVVD secured FDA F [Read more]